NASDAQ:AKBA | Free Cash Flow | Akebia Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$21.21M$62,000.00-$21.27M
2025-12-31$31.13M$70,000.00$31.06M
2025-03-31-$13.59M$18,000.00-$13.61M-222.59%
2024-12-31-$4.47M$2,000.00-$4.47M
2024-03-31-$19.43M$0.00-$19.43M
2023-12-31-$2.31M$0.00-$2.31M-375.90%
2023-03-31-$17.54M$0.00-$17.54M
2022-12-31-$54.68M$0.00-$54.68M
2022-03-31-$21.62M$114,000.00-$21.73M
2021-12-31-$62.81M$0.00-$62.81M
2021-03-31-$70.75M$59,000.00-$70.81M
2020-12-31-$30.78M$317,000.00-$31.1M
2020-03-31-$89.59M$0.00-$89.59M
2019-12-31-$92.14M$220,000.00-$92.36M
2019-03-31-$137.93M$1.93M-$139.86M
2018-12-31-$73.7M$830,000.00-$74.53M
2018-03-31-$20.33M$296,000.00-$20.63M
2017-12-31-$16.38M$450,000.00-$16.83M-108.41%
2017-03-31-$9.53M$427,000.00-$9.96M
2016-12-31$95.67M$48,000.00$95.62M
2016-03-31$17.43M$109,000.00$17.33M
2015-12-31-$22.91M$72,000.00-$22.98M
2015-03-31-$8.35M$200,000.00-$8.55M
2014-12-31-$9.2M$21,000.00-$9.22M
2014-03-31-$6.01M$142,000.00-$6.15M
2013-12-31-$4.91M$13,000.00-$4.92M
2013-03-31-$1.53M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$67.99M$291,000.00$67.7M
2024-12-31-$40.66M$33,000.00-$40.69M
2023-12-31-$23.38M$0.00-$23.38M
2022-12-31-$73.15M$114,000.00-$73.27M
2021-12-31-$252.97M$59,000.00-$253.02M
2020-12-31-$110.39M$317,000.00-$110.71M
2019-12-31-$257.44M$6.66M-$264.1M
2018-12-31-$97.49M$1.61M-$99.1M
2017-12-31-$56.16M$1.62M-$57.78M
2016-12-31$57.91M$2.66M$55.24M
2015-12-31-$52.41M$414,000.00-$52.82M
2014-12-31-$27.48M$229,000.00-$27.71M
2013-12-31-$11.33M$19,000.00-$11.35M
2012-12-31-$7.21M